AMEREN CORP — Form 8-K
Filed August 4, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 38/100
What the filing says
Ameren Corporation filed an effective Form S-3 registration statement on August 4, 2026, registering up to $2,266,700,000 in common stock for sale under an Equity Distribution Sales Agreement with nine sales agents (Barclays, BofA, Goldman Sachs, JPMorgan, Mizuho, Morgan Stanley, MUFG, RBC, Wells Fargo). The agreement, originally dated May 12, 2021 and amended August 7, 2025, includes forward sale and forward purchase provisions. This is a legal opinion confirming the shares will be validly issued, fully paid, and non-assessable.
Why this rating
$2.27B offering is ~8.8% of $25.9B market cap—meaningful for equity financing but routine shelf-registration mechanics. No imminent capital raise disclosed; authorization only.
See more from August 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.